BD2, an organization funding large-scale bipolar research, unveiled a new research collaboration on March 30, 2023, to further understanding of the genetic basis of bipolar disorder. The collaboration is headed by The Broad Institute of MIT and Harvard and includes the New York Genome Center and the UCLA Center for Neurobehavioral Genetics, led by UCLA Depression Grand Challenge Director Nelson Freimer, MD.